Search research articles
Contact Us
Filters
Showing results (11-20 of 130) with videos related to
Page
of 13
Sort By:
Pharmacological Research
|
September 1, 2018
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Pedro Miguel Lacal, Grazia Graziani
Chemotherapy
|
November 3, 2015
Editorial
Giorgio Minotti, Grazia Graziani, Giovanni Delogu
Pharmacological Research
|
February 16, 2002
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
Lucio Tentori, Ilaria Portarena, Grazia Graziani
Pharmacological Research
|
May 25, 2005
PARP-1 inhibition to treat cancer, ischemia, inflammation
Grazia Graziani, Fiorenzo Battaini, Jie Zhang
Pharmacological Research
|
September 21, 2011
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer
Grazia Graziani, Lucio Tentori, Pierluigi Navarra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Clinical applications of telomerase in cancer treatment
Isabella Faraoni, Enzo Bonmassar, Grazia Graziani
Pharmacology & Therapeutics
|
January 6, 2022
Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential
Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani
Trends in Pharmacological Sciences
|
November 12, 2013
Challenging resistance mechanisms to therapies for metastatic melanoma
Lucio Tentori, Pedro Miguel Lacal, Grazia Graziani
Experientia Supplementum (2012)
|
February 15, 2022
Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab
Grazia Graziani, Lucia Lisi, Lucio Tentori, et al.
Nanotechnology
|
May 8, 2020
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers
Claudia Ceci, Grazia Graziani, Isabella Faraoni, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 130) with videos related to
Sort By:
Page
of 13
Pharmacological Research
|
September 1, 2018
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Pedro Miguel Lacal, Grazia Graziani
Chemotherapy
|
November 3, 2015
Editorial
Giorgio Minotti, Grazia Graziani, Giovanni Delogu
Pharmacological Research
|
February 16, 2002
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
Lucio Tentori, Ilaria Portarena, Grazia Graziani
Pharmacological Research
|
May 25, 2005
PARP-1 inhibition to treat cancer, ischemia, inflammation
Grazia Graziani, Fiorenzo Battaini, Jie Zhang
Pharmacological Research
|
September 21, 2011
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer
Grazia Graziani, Lucio Tentori, Pierluigi Navarra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Clinical applications of telomerase in cancer treatment
Isabella Faraoni, Enzo Bonmassar, Grazia Graziani
Pharmacology & Therapeutics
|
January 6, 2022
Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential
Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani
Trends in Pharmacological Sciences
|
November 12, 2013
Challenging resistance mechanisms to therapies for metastatic melanoma
Lucio Tentori, Pedro Miguel Lacal, Grazia Graziani
Experientia Supplementum (2012)
|
February 15, 2022
Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab
Grazia Graziani, Lucia Lisi, Lucio Tentori, et al.
Nanotechnology
|
May 8, 2020
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers
Claudia Ceci, Grazia Graziani, Isabella Faraoni, et al.
Page
of 13